Campbell & Co. Investment Adviser »

Agios Pharmaceuticals shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.7M 73k 37.11
2025-12-31 $224k 8.2k 27.22
2022-06-30 $367k 17k 22.16

More positions owned by Campbell & Co. Investment Adviser

Hilton Worldwide Holdings Common Stock (HLT)
Petroleo Brasileiro SA - Petro Adr (PBR)
Darling Ingredients Common Stock (DAR)
Hartford Insurance Group Inc/T Common Stock (HIG)
Atmos Energy Corp Common Stock (ATO)
Marriott International Common Stock (MAR)
LyondellBasell Industries NV Common Stock (LYB)
Westlake Corp Common Stock (WLK)
Mettler-Toledo International I Common Stock (MTD)
Labcorp Holdings Common Stock (LH)
Loews Corp Common Stock (L)
US Bancorp Common Stock (USB)
Primerica Common Stock (PRI)
Mastercard Common Stock (MA)
Wells Fargo & Co Common Stock (WFC)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Agios Pharmaceuticals

BlackRock
Farallon Capital Management
Armistice Capital
Lynx1 Capital Management
State Street Corporation
D. E. Shaw & Co
Vanguard Portfolio Management
Vanguard Capital Management
Erste Asset Management GmbH
Nomura Asset Management International
Susquehanna International
Geode Capital Management
ADAR1 Capital Management
Bnp Paribas Investment Partners
Dimensional Fund Advisors

View all funds holding Agios Pharmaceuticals